Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Stock Symbol
-
JANX on Nasdaq
There are no Buy or Sell transactions made by Orbimed Advisors Llc since 10/5/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
231K |
$1.36M |
$5.87 |
Dec 29, 2021 |
Indirect |
|
|
| Series A Convertible Preferred Stock |
0 |
|
|
Jun 15, 2021 |
Indirect |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
Jun 15, 2021 |
Indirect |
Common Stock |
|
Transactions reported by Orbimed Advisors Llc for Janux Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.